MedTrace Logo

Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline

NCT04682977 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-08-19

Study results available
· View outcomes & findings →

Summary

Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an occupational therapist-delivered primary care intervention for aging and chronic disease management.

Conditions

  • Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease)
  • Uncontrolled Diabetes (HBA1c ≥ 10)

Interventions

OTHER

IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning)

IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning) is an intervention designed to be delivered in primary care settings by an on-site occupational therapist. Based on the premise of preventing the physical and cognitive decline that is associated with aging and chronic disease, the 12-week intervention includes a comprehensive assessment of ADL functioning and ten intervention sessions addressing disease management, physical activity and executive functioning.

OTHER

Usual primary care services

Usual primary care services might include monitoring of vitals and other relevant laboratory testing, prescription of medications for chronic disease management, as well as counseling for lifestyle changes.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Mansha Mirza, PhD, OTR/L · University of Illinois at Chicago

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-11
Primary Completion
2024-03-01
Completion
2024-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04682977 on ClinicalTrials.gov